Drug Database
Back to search

Germany· DE-A57-583a04aa61a47a0c

Vincristinsulfat Teva

A vincristine product containing vincristine sulfate, registered in Germany by Teva Gmbh. The same ATC class is registered in 16 of our 19 countries.

ATC L01CA02

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedVincristinsulfat TevaATCL01CA02REGISTER NO.DE-A57-583a04aa61a47a…PACKS LISTED0CHECKEDAugust 5, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about vincristine sulfateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Vincristine is registered in 16 of 19 countries.

Countries holding a registration under ATC L01CA02 (vincristine), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 9 of them publish a price we can compare per daily dose
Search vincristine products by name

Vincristine · ATC L01CA02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Vincristine Sulfate
Manufacturer
Teva Gmbh
Country
Germany (DE)
ATC code
L01CA02
ATC class
Vincristine
Defined daily dose
0.36 mg, P
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
August 5, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

583 interactions on record for vincristine.

Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check vincristine against other medicinesHow interaction checks work

Vincristine · interactions on record

583 records

  • 63 severe
  • 282 moderate
  • 25 minor
  • 213 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vincristine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vincristine products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Oncovin, Vincristin Pfizer
  • Belgium · Vincrisin
  • Czechia · Vincristine Teva
  • Denmark · Oncovin
  • Spain · Vincristina Pfizer
  • Finland · Oncovin
  • France · Oncovin, Vincristine Hospira
  • United Kingdom (Northern Ireland) · Vincristine Sulfate Hospira Uk, Vincristine Sulfate Teva Uk
  • Ireland · Vincristine Sulfate Pfizer Healthcare Ireland
  • Italy · Vincristina, Vincristina Pfizer Italia
  • Lithuania · Vincristine Teva
  • Luxembourg · Vincrisin
  • Latvia · Vincristine Teva
  • Netherlands · Vincristinesulfaat Teva
  • Norway · Vincristine Pfizer
  • Poland · Vincristine Teva
  • Portugal · Vincristina Teva
  • Romania · Sindovin, Vincristină Teva
  • Sweden · Oncovin, Vincristine Pfizer

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d97d1279-7914-46f0-ae1d-6f95eb2c8b8c
GET /v1/drugs/d97d1279-7914-46f0-ae1d-6f95eb2c8b8c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Epidural Use, Intrabursal Use, Intracoronary Use, Intradiscal Use, Intramuscular Use, Intravenous Use, Perineural Use, Retrobulbar Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Vincristine Sulfate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about vincristine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console